Status:
NOT_YET_RECRUITING
Evaluation of Study Experiences of Neuroendocrine Tumor Patients
Lead Sponsor:
Power Life Sciences Inc.
Conditions:
Neuroendocrine Tumors
Eligibility:
All Genders
18+ years
Brief Summary
Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demograph...
Eligibility Criteria
Inclusion
- Patient is at least 18 years of age
- Diagnosis of neuroendocrine tumor
- Ability to understand and the willingness to sign a written informed consent document
Exclusion
- Enrolled in another research study
- Patients with psychiatric illness/social situations that would limit compliance with study requirements
- Pregnant or lactating woman
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05967481
Start Date
August 1 2024
End Date
August 1 2026
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Power Life Sciences
San Francisco, California, United States, 94107